Daxiang Biotech joined global leaders in Microphysiological Systems (MPS) research and innovation at MPS World Summit 2026, where the company showcased its integrated Organoids-on-Chips platform and engaged with researchers, industry partners, and innovators from around the world.

Daxiang Biotech utilized the IBAC O2 chip to construct a tumor organoid immune co-culture model. This model effectively recreated the immune microenvironment of human tumors and evaluated the efficacy of QLF3108.

Humanized and highly advanced organoids on chips models have emerged as a crucial technology platform for evaluating cell therapy drugs and conducting translational medicine research. Data of organoids on chips facilitate clinical approval of CAR-T drugs for solid tumors.

On April 12, 2022, Daxiang Biotech and Nikon signed a strategic cooperation agreement .